Press Releases

Biocon Biologics  /  Press Releases

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

  • Posted by: Biocon Biologics

Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency

  • Posted by: Biocon Biologics

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year

  • Posted by: Biocon Biologics

Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.

  • Posted by: Biocon Biologics

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France

  • Posted by: Biocon Biologics

Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency

  • Posted by: Biocon Biologics

Biocon’s Insulin Glargine Launched in Japan

  • Posted by: Biocon Biologics

Biocon, Quark Announce Initiation of Pivotal Phase II/III Study of QPI-1007 in Rare Eye Disease in India

  • Posted by: Biocon Biologics

Mylan and Biocon to Present Phase 3 Trastuzumab Biosimilar Data at the American Society of Clinical Oncology (ASCO) Annual Meeting

  • Posted by: Biocon Biologics

Biocon’s Insulin Glargine Receives Regulatory Approval in Japan

  • Posted by: Biocon Biologics
Share